Exact Mass: 458.24569640000004
Exact Mass Matches: 458.24569640000004
Found 500 metabolites which its exact mass value is equals to given mass value 458.24569640000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Astemizole
C28H31FN4O (458.24817679999995)
Astemizole is a long-acting, non-sedating second generation antihistamine used in the treatment of allergy symptoms. It was withdrawn from market by the manufacturer in 1999 due to the potential to cause arrhythmias at high doses, especially when when taken with CYP inhibitors or grapefruit juice. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Astemizole (R 43512), a second-generation antihistamine agent to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects[1][2].
fumagillin
A meroterpenoid resulting from the formal condensation of the hydroxy group of fumagillol with the carboxylic acid group of (all-E)-deca-2,4,6,8-tetraenedioic acid. Originally isolated from the fungus Aspergillus fumigatus, it is used for the control of Nosema infection in honey bees. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D006133 - Growth Substances > D006131 - Growth Inhibitors Fumagillin(NSC9168) is an antimicrobial compound first isolated in 1949 from the fungus Aspergillus fumigatu. Fumagillin can inhibits HIV‐1 infection through the inhibition of HIV-1 viral protein R (Vpr) activity.
Cinobufotalin
Cinobufotalin is a natural product found in Bufo and Bufo bufo with data available. Cinobufotalin is a bufadienolide isolated from toad venom and utilized in traditional Chinese medicine (TCM) for its cardiotonic, diuretic and hemostatic effects, with potential cytotoxic and antineoplastic activities. Upon administration and although the exact mechanism of action(s) (MoAs) through which this agent exerts its effects have yet to be fully discovered, cinobufotalin causes DNA fragmentation, decreases mitochondrial membrane potential (MMP), increases intracellular calcium (Ca2+) ion concentrations and reactive oxygen species (ROS) production, upregulates Fas protein and activates cytochrome C, various caspases, Bid and Bax. This causes cell cycle arrest, induces apoptosis and inhibits tumor cell growth and survival. In addition, cinobufotalin inhibits the activity of sphingosine kinase 1 (SphK1) and induces pro-apoptotic ceramide production, which further promotes tumor cell apoptosis. Cinobufotalin also induces mitochondrial protein cyclophilin D (Cyp-D)-dependent opening of the mitochondrial permeability transition pore (mPTP), which may contribute to cinobufotalin-induced non-apoptotic death of certain tumor cells. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides Cinobufotalin is a cardiotonic steroids or bufadienolides, is extracted from the skin secretions of the giant toads. Cinobufotalin has been used as a cardiotonic, diuretic and a hemostatic agent, Cinobufotalin is also a potential anti-lung cancer agent[1].
[6]-Gingerdiol 5-O-beta-D-glucopyranoside
[6]-Gingerdiol 5-O-beta-D-glucopyranoside is found in herbs and spices. [6]-Gingerdiol 5-O-beta-D-glucopyranoside is a constituent of ginger (Zingiber officinale) rhizomes
[6]-Gingerdiol 4'-O-beta-D-glucopyranoside
[6]-Gingerdiol 4-O-beta-D-glucopyranoside is found in herbs and spices. [6]-Gingerdiol 4-O-beta-D-glucopyranoside is a constituent of ginger (Zingiber officinale) rhizomes
3-Sulfodeoxycholic acid
Deoxycholic Acid/analogs and derivatives.
1-Lyso-2-arachidonoyl-phosphatidate
LPA(0:0/20:4n6) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells.LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293) [HMDB] LPA(0:0/20:4n6) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells.LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).
Hydroxystrobilurin D
Hydroxystrobilurin D is found in mushrooms. Hydroxystrobilurin D is isolated from Mycena sanguinolenta (blood mycena Isolated from Mycena sanguinolenta (blood mycena). Hydroxystrobilurin D is found in mushrooms.
LysoPA(20:4(5Z,8Z,11Z,14Z)/0:0)
1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate is also known as LPA(20:4(5Z,8Z,11Z,14Z)/0:0) or 1-Arachidonoyl lpa. 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:4(8Z,11Z,14Z,17Z)/0:0)
LysoPA(20:4(8Z,11Z,14Z,17Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:4(8Z,11Z,14Z,17Z)/0:0), in particular, consists of one chain of eicosatetraenoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
fumagillin
Cinobufotalin
Cinobufotalin is a cardiotonic steroids or bufadienolides, is extracted from the skin secretions of the giant toads. Cinobufotalin has been used as a cardiotonic, diuretic and a hemostatic agent, Cinobufotalin is also a potential anti-lung cancer agent[1].
(E)-8-(2-(4-(Diphenylamino)benzylidene)hydrazinyl)-N-hydroxy-8-oxooctanamide
C27H30N4O3 (458.23177899999996)
3-Prenylrubranine
Sophoranochromene
Sophoradochromene
(5S)--5,6,7,7a,7b,12b-hexahydro-3,4,5,11,12b-pentamethyl-10-[(3E)-pent-3-en-1-yl]-furo[3,2:6,7]naphthol[1,8:4,5,6]pyrano[3,2-b]benzofuran-9-ol
3alpha,11alpha-cyclotaxinine NN-2|3alpha,9alpha,10beta-triacetoxy-3alpha,11alpha-cyclotaxa-4(20),5-dien-13-one
(2E)-1-(3,4-dihydro-5-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-3-[2,2-dimethyl-8-(3-methylbut-2-enyl)-2H-1-benzopyran-6-yl]prop-2-en-1-one|tokinochromane C
6beta,9beta-diacetoxy-1alpha-benzoyloxydihydro-beta-agarofuran
9-hydroxy-gamma-geraniol-1-O-(6-isovaleryl-3-acetyl-beta-D-glucopyranoside)
{(Z)-3-(chloromethylene)-2,3-dihydrobenzo[b]oxepin-7-yl}methyl palmitoleate
C28H39ClO3 (458.25875740000004)
berkeleyone B
A meroterpenoid found in Penicillium rubrum and has been shown to exhibit inhibitory activity against caspase-1.
berkeleyone C
A meroterpenoid found in Penicillium rubrum and has been shown to exhibit inhibitory activity against caspase-1.
(3S,4R)-4-([(1S,2R,4aR,5R,8aS)-decahydro-2-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethylnaphthalen-1-yl]methoxy)-5-methoxy-3-(methoxycarbonyl)-5-oxopentanoic acid|cryptoporic acid K
pierisformotoxin D|rel-(3beta,6beta,7alpha,14R)-3,5,7,10,14,15,16-heptahydroxygrayanotoxan-6-yl propanoate
Hydroxystrobilurin D
9-Acetoxy-gamma-geraniol-1-O-<3-(2-methylbutanoyl)>-beta-D-glucopyranoside|9-Acetoxy-gamma-geraniol-1-O-[3-(2-methylbutanoyl)]-beta-D-glucopyranoside
9-Hydroxy-gamma-geraniol-1-O-<6-acetyl-3-(2-methylbutanoyl)>-beta-D-glucopyranoside|9-Hydroxy-gamma-geraniol-1-O-[6-acetyl-3-(2-methylbutanoyl)]-beta-D-glucopyranoside
lespeflorin A3
A monohydroxyflavanone that is flavanone substituted with a hydroxy group at position 7, prenyl groups at positions 6 and 8 and a 6,6-dimethyl-3,6-dihydro-2H-pyran ring fused across positions 3 and 4. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
Ala Ile Gln Gln
Ala Leu Gln Gln
Ala Asn Arg Val
Ala Asn Val Arg
Ala Gln Ile Gln
Ala Gln Leu Gln
Ala Gln Gln Ile
Ala Gln Gln Leu
Ala Arg Asn Val
Ala Arg Val Asn
Ala Val Asn Arg
Ala Val Arg Asn
Glu Ile Pro Thr
Glu Ile Thr Pro
Glu Leu Pro Thr
Glu Leu Thr Pro
Glu Pro Ile Thr
Glu Pro Leu Thr
Glu Pro Thr Ile
Glu Pro Thr Leu
Glu Thr Ile Pro
Glu Thr Leu Pro
Glu Thr Pro Ile
Glu Thr Pro Leu
Phe Pro Pro Val
Phe Pro Val Pro
Phe Val Pro Pro
Gly Ile Asn Arg
Gly Ile Arg Asn
Gly Leu Asn Arg
Gly Leu Arg Asn
Gly Asn Ile Arg
Gly Asn Leu Arg
Gly Asn Arg Ile
Gly Asn Arg Leu
Gly Gln Arg Val
Gly Gln Val Arg
Gly Arg Ile Asn
Gly Arg Leu Asn
Gly Arg Asn Ile
Gly Arg Asn Leu
Gly Arg Gln Val
Gly Arg Val Gln
Gly Val Gln Arg
Gly Val Arg Gln
Ile Ala Gln Gln
Ile Glu Pro Thr
Ile Glu Thr Pro
Ile Gly Asn Arg
Ile Gly Arg Asn
Ile Met Pro Val
Ile Met Val Pro
Ile Asn Gly Arg
Ile Asn Asn Val
Ile Asn Arg Gly
Ile Asn Val Asn
Ile Pro Glu Thr
Ile Pro Met Val
Ile Pro Thr Glu
Ile Pro Val Met
Ile Gln Ala Gln
Ile Gln Gln Ala
Ile Arg Gly Asn
Ile Arg Asn Gly
Ile Thr Glu Pro
Ile Thr Pro Glu
Ile Val Met Pro
Ile Val Asn Asn
Ile Val Pro Met
Lys Asn Pro Thr
Lys Asn Thr Pro
Lys Pro Asn Thr
Lys Pro Gln Ser
Lys Pro Ser Gln
Lys Pro Thr Asn
Lys Gln Pro Ser
Lys Gln Ser Pro
Lys Ser Pro Gln
Lys Ser Gln Pro
Lys Thr Asn Pro
Lys Thr Pro Asn
Leu Ala Gln Gln
Leu Glu Pro Thr
Leu Glu Thr Pro
Leu Gly Asn Arg
Leu Gly Arg Asn
Leu Met Pro Val
Leu Met Val Pro
Leu Asn Gly Arg
Leu Asn Asn Val
Leu Asn Arg Gly
Leu Asn Val Asn
Leu Pro Glu Thr
Leu Pro Met Val
Leu Pro Thr Glu
Leu Pro Val Met
Leu Gln Ala Gln
Leu Gln Gln Ala
Leu Arg Gly Asn
Leu Arg Asn Gly
Leu Thr Glu Pro
Leu Thr Pro Glu
Leu Val Met Pro
Leu Val Asn Asn
Leu Val Pro Met
Met Ile Pro Val
Met Ile Val Pro
Met Leu Pro Val
Met Leu Val Pro
Met Pro Ile Val
Met Pro Leu Val
Met Pro Val Ile
Met Pro Val Leu
Met Val Ile Pro
Met Val Leu Pro
Met Val Pro Ile
Met Val Pro Leu
Asn Ala Arg Val
Asn Ala Val Arg
Asn Gly Ile Arg
Asn Gly Leu Arg
Asn Gly Arg Ile
Asn Gly Arg Leu
Asn Ile Gly Arg
Asn Ile Asn Val
Asn Ile Arg Gly
Asn Ile Val Asn
Asn Lys Pro Thr
Asn Lys Thr Pro
Asn Leu Gly Arg
Asn Leu Asn Val
Asn Leu Arg Gly
Asn Leu Val Asn
Asn Asn Ile Val
Asn Asn Leu Val
Asn Asn Val Ile
Asn Asn Val Leu
Asn Pro Lys Thr
Asn Pro Thr Lys
Asn Gln Val Val
Asn Arg Ala Val
Asn Arg Gly Ile
Asn Arg Gly Leu
Asn Arg Ile Gly
Asn Arg Leu Gly
Asn Arg Val Ala
Asn Thr Lys Pro
Asn Thr Pro Lys
Asn Val Ala Arg
Asn Val Ile Asn
Asn Val Leu Asn
Asn Val Asn Ile
Asn Val Asn Leu
Asn Val Gln Val
Asn Val Arg Ala
Asn Val Val Gln
Pro Glu Ile Thr
Pro Glu Leu Thr
Pro Glu Thr Ile
Pro Glu Thr Leu
Pro Phe Pro Val
Pro Phe Val Pro
Pro Ile Glu Thr
Pro Ile Met Val
Pro Ile Thr Glu
Pro Ile Val Met
Pro Lys Asn Thr
Pro Lys Gln Ser
Pro Lys Ser Gln
Pro Lys Thr Asn
Pro Leu Glu Thr
Pro Leu Met Val
Pro Leu Thr Glu
Pro Leu Val Met
Pro Met Ile Val
Pro Met Leu Val
Pro Met Val Ile
Pro Met Val Leu
Pro Asn Lys Thr
Pro Asn Thr Lys
Pro Pro Phe Val
Pro Pro Val Phe
Pro Gln Lys Ser
Pro Gln Ser Lys
Pro Ser Lys Gln
Pro Ser Gln Lys
Pro Thr Glu Ile
Pro Thr Glu Leu
Pro Thr Ile Glu
Pro Thr Lys Asn
Pro Thr Leu Glu
Pro Thr Asn Lys
Pro Val Phe Pro
Pro Val Ile Met
Pro Val Leu Met
Pro Val Met Ile
Pro Val Met Leu
Pro Val Pro Phe
Gln Ala Ile Gln
Gln Ala Leu Gln
Gln Ala Gln Ile
Gln Ala Gln Leu
Gln Gly Arg Val
Gln Gly Val Arg
Gln Ile Ala Gln
Gln Ile Gln Ala
Gln Lys Pro Ser
Gln Lys Ser Pro
Gln Leu Ala Gln
Gln Leu Gln Ala
Gln Asn Val Val
Gln Pro Lys Ser
Gln Pro Ser Lys
Gln Gln Ala Ile
Gln Gln Ala Leu
Gln Gln Ile Ala
Gln Gln Leu Ala
Gln Arg Gly Val
Gln Arg Val Gly
Gln Ser Lys Pro
Gln Ser Pro Lys
Gln Val Gly Arg
Gln Val Asn Val
Gln Val Arg Gly
Gln Val Val Asn
Arg Ala Asn Val
Arg Ala Val Asn
Arg Gly Ile Asn
Arg Gly Leu Asn
Arg Gly Asn Ile
Arg Gly Asn Leu
Arg Gly Gln Val
Arg Gly Val Gln
Arg Ile Gly Asn
Arg Ile Asn Gly
Arg Leu Gly Asn
Arg Leu Asn Gly
Arg Asn Ala Val
Arg Asn Gly Ile
Arg Asn Gly Leu
Arg Asn Ile Gly
Arg Asn Leu Gly
Arg Asn Val Ala
Arg Gln Gly Val
Arg Gln Val Gly
Arg Val Ala Asn
Arg Val Gly Gln
Arg Val Asn Ala
Arg Val Gln Gly
Ser Lys Pro Gln
Ser Lys Gln Pro
Ser Pro Lys Gln
Ser Pro Gln Lys
Ser Gln Lys Pro
Ser Gln Pro Lys
Thr Glu Ile Pro
Thr Glu Leu Pro
Thr Glu Pro Ile
Thr Glu Pro Leu
Thr Ile Glu Pro
Thr Ile Pro Glu
Thr Lys Asn Pro
Thr Lys Pro Asn
Thr Leu Glu Pro
Thr Leu Pro Glu
Thr Asn Lys Pro
Thr Asn Pro Lys
Thr Pro Glu Ile
Thr Pro Glu Leu
Thr Pro Ile Glu
Thr Pro Lys Asn
Thr Pro Leu Glu
Thr Pro Asn Lys
Val Ala Asn Arg
Val Ala Arg Asn
Val Phe Pro Pro
Val Gly Gln Arg
Val Gly Arg Gln
Val Ile Met Pro
Val Ile Asn Asn
Val Ile Pro Met
Val Leu Met Pro
Val Leu Asn Asn
Val Leu Pro Met
Val Met Ile Pro
Val Met Leu Pro
Val Met Pro Ile
Val Met Pro Leu
Val Asn Ala Arg
Val Asn Ile Asn
Val Asn Leu Asn
Val Asn Asn Ile
Val Asn Asn Leu
Val Asn Gln Val
Val Asn Arg Ala
Val Asn Val Gln
Val Pro Phe Pro
Val Pro Ile Met
Val Pro Leu Met
Val Pro Met Ile
Val Pro Met Leu
Val Pro Pro Phe
Val Gln Gly Arg
Val Gln Asn Val
Val Gln Arg Gly
Val Gln Val Asn
Val Arg Ala Asn
Val Arg Gly Gln
Val Arg Asn Ala
Val Arg Gln Gly
Val Val Asn Gln
Val Val Gln Asn
LysoPA(20:4/0:0)
N-(4-benzenesulfonamide)arachidonoyl amide
[6]-Gingerdiol 4'-O-beta-D-glucopyranoside
[6]-Gingerdiol 5-O-beta-D-glucopyranoside
1-oleoyl-sn-glycero-3-phosphate sodium salt
C21H40NaO7P (458.24092200000007)
1-(4-Phenylboronic acid pinacol ester)-1,2,2-triphenylethene
C32H31BO2 (458.24169759999995)
N-hydroxy-N-[(E)-[4-(N-phenylanilino)phenyl]methylideneamino]octanediamide
C27H30N4O3 (458.23177899999996)
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors D000970 - Antineoplastic Agents
3-[(3-Aminomethyl-biphenyl-4-carbonyl)-amino]-2-(3-carbamimidoyl-benzyl)-butyric acid methyl ester
C27H30N4O3 (458.23177899999996)
[6]-Gingerdiol 4'-O-beta-D-glucopyranoside
[6]-Gingerdiol 4-O-beta-D-glucopyranoside is found in herbs and spices. [6]-Gingerdiol 4-O-beta-D-glucopyranoside is a constituent of ginger (Zingiber officinale) rhizomes Constituent of ginger (Zingiber officinale) rhizomes. [6]-Gingerdiol 4-glucoside is found in herbs and spices.
[6]-Gingerdiol 5-O-beta-D-glucopyranoside
[6]-Gingerdiol 5-O-beta-D-glucopyranoside is found in herbs and spices. [6]-Gingerdiol 5-O-beta-D-glucopyranoside is a constituent of ginger (Zingiber officinale) rhizomes Constituent of ginger (Zingiber officinale) rhizomes. [6]-Gingerdiol 5-glucoside is found in herbs and spices.
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedioate
C30H34O4-2 (458.24569640000004)
[(1S,2R,3R,4S,5R)-5-azaniumyl-2-[(2S,3R,4R,5S,6R)-3-azaniumyl-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxycyclohexyl]azanium
[(1S,2R,3R,4S,5R)-5-azaniumyl-2-[(2R,3R,4R,5S,6R)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxycyclohexyl]azanium
C17H38N4O10+4 (458.25878079999995)
Homoplatensimide A
A polycyclic cage compound isolated from Streptomyces platensis.
3-[[cyclopentyl-[[1-[(4-methoxyphenyl)methyl]-5-tetrazolyl]methyl]amino]methyl]-7-methyl-1H-quinolin-2-one
C26H30N6O2 (458.24301199999996)
3-[3,4-dihydro-1H-isoquinolin-2-yl-[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]-7-methoxy-1H-quinolin-2-one
C26H30N6O2 (458.24301199999996)
cyclobutyl-[(8R,9R,10R)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
cyclobutyl-[(8R,9S,10R)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
cyclobutyl-[(8S,9S,10R)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
cyclobutyl-[(8S,9S,10S)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1-(3-fluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
cyclobutyl-[(8R,9S,10S)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1-(3-fluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide
1-(3-fluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-(2-oxo-2-piperidin-1-ylethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]oxane-4-carboxamide
1-(3-fluorophenyl)-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
1-(2-fluorophenyl)-3-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
cyclobutyl-[(8S,9R,10R)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
cyclobutyl-[(8S,9R,10S)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
1-(3-fluorophenyl)-3-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-fluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-isoxazolecarboxamide
1-(2-fluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-fluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-fluorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(1-piperidinyl)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-4-oxanecarboxamide
cyclobutyl-[(8R,9R,10S)-10-(hydroxymethyl)-9-[4-[2-(2-methoxyphenyl)ethynyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-6-yl]methanone
(1S)-1-(hydroxymethyl)-7-methoxy-2-(2-methoxy-1-oxoethyl)-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1R)-1-(hydroxymethyl)-7-methoxy-2-(2-methoxy-1-oxoethyl)-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
L-alanyl-L-phenylalanyl-L-proline 2-naphthylamide
C27H30N4O3 (458.23177899999996)
astemizole
C28H31FN4O (458.24817679999995)
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Astemizole (R 43512), a second-generation antihistamine agent to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects[1][2].
1-arachidonoyl-sn-glycerol 3-phosphate
A 1-acyl-sn-glycerol 3-phosphate in which the 1-O-acyl group is specified as arachidonoyl.
Ribostamycin(4+)
C17H38N4O10 (458.25878079999995)
An organic cation obtained by protonation of the four amino groups of ribostamycin; major species at pH 7.3.
4,4-diapolycopenedioate
A dicarboxylic acid dianion derived from 4,4-diapolycopen-4,4-dioic acid. Major structure at pH 7.3,
2-Arachidonoyl-sn-glycero-3-phosphate
A 2-acyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl group is specified as arachidonoyl.
BIX 02565
C26H30N6O2 (458.24301199999996)
BIX 02565 is a potent ribosomal S6 kinase 2 (RSK2) inhibitor with IC50 of 1.1 nM.